Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry.,Prostate Cancer and Prostatic Diseases - X-MOL
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study - The Lancet Oncology
Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer - European Urology
prostate cancer and hormones
Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer - Clinical Genitourinary Cancer
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer - European Urology
ANO7 rs77559646 Is Associated With First-line Docetaxel Treatment Response in Metastatic Castration-resistant Prostate Cancer | Anticancer Research
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer - Annals of Oncology
A) Prostate cancer–specific survival and (B) overall survival... | Download Scientific Diagram
Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database | Scientific Reports
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England | Prostate Cancer and Prostatic Diseases
Overall survival rate of patients with T3a and T3b stage prostate... | Download Scientific Diagram
Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China | Oncotarget
Recent Advances in the Management of Metastatic Prostate Cancer | JCO Oncology Practice
Overall survival of metastatic prostate cancer patients starting... | Download Scientific Diagram
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial - Annals of Oncology
Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018) | BMC Cancer | Full Text
PLOS ONE: Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH - ScienceDirect
